| Similar Articles |
|---|
 |
The Motley Fool
December 10, 2010
Sean Williams |
ICU Medical: Bargain or Value Trap? International sales growth will be the key to the medical supplier's long-term success.   |
The Motley Fool
January 31, 2006
Stephen D. Simpson |
Guidance Puts ICU Medical in the Trauma Ward This oft-volatile stock had a strong fourth quarter, but weak guidance. Even with today's steep drop in price, the shares aren't cheap enough to be interesting. |
The Motley Fool
May 13, 2005
Brian Gorman |
Hospira's Hopeful Signs The medical products company's strong quarter belies a less exciting future. Investors should probably take a wait-and-see attitude. |
The Motley Fool
January 18, 2012
Sean Williams |
Are These 2 Medical Device Makers Takeover Targets? Could these two medical device makers put themselves up for sale in 2012? |
The Motley Fool
November 10, 2005
Stephen D. Simpson |
Hospitable Treatment for Hospira Solid margins fuel strong earnings at the hybrid generics - medical distributor. Buying this stock wisely may be the key to good long-term returns. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
Riding the Hospira Yo-Yo There's a solid foundation on this roller coaster pharmaceutical and drug delivery company. Maybe Hospira's current valuation doesn't make it a "gem," but that's not really within its control. |
The Motley Fool
July 13, 2011 |
ICU Medical Earnings Preview Medical systems maker ICU Medical will unveil its latest earnings on Monday, July 18. Investors never know what to expect for the company, as it has wavered between topping and missing analysts estimates during the past fiscal year. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
The Motley Fool
January 20, 2011
Jeremy Phillips |
Time to Sell Hospira? Hospira has failed two of the quick tests that would make it a sell. This is great, but does it mean you should hold your Hospira shares? |
The Motley Fool
August 10, 2006
Stephen D. Simpson |
Volatility, Thy Name Is Hospira Margins continue to stand in the way of consistent performance at the health-care company. Investors, take note. |
The Motley Fool
July 22, 2009
Chris Jones |
Are These Winners Worth the Risk? Will medical device and supply stocks keep posting big gains? |
The Motley Fool
May 12, 2008
Chuck Saletta |
How to Compete Successfully Against Giants Small businesses have an opening they can use to profit from opportunities the giants leave behind. |
The Motley Fool
July 8, 2010
Selena Maranjian |
Get 2-for-1 Stock-Price Growth This one-two punch can lead to serious gains. Stocks that offer both earnings growth and P/E growth can help you rack up knockout returns over the long haul. |
The Motley Fool
March 1, 2006
Brian Gorman |
Hospira's Stumble In spite of an unsightly quarter, good things still are happening at this medical products and services outfit. Investors, take note. |
The Motley Fool
August 8, 2007
Ryan Fuhrmann |
Hospira Looks to Deliver Will a recent acquisition boost drug delivery firm Hospira's growth prospects? The new Mayne Pharma Limited division played a primary role in delivering an impressive 30% reported sales growth. |
The Motley Fool
November 9, 2006
Brian Lawler |
Hospira's Flatlining Sales There's no good news to be found in this medical products supplier's medicine chest. The upcoming fourth quarter isn't going to be any better, either. Investors, take note. |
BusinessWeek
May 31, 2004
Robert Barker |
Hospira Just May Put You In The Pink If the Abbott Laboratories spin-off's first steps hardly seem promising, that's one reason why I see the company as worth much more of the intelligent investor's attention than the long calendar of pending tech and biotech IPOs. |
The Motley Fool
November 11, 2004
Brian Gorman |
Hospira's Possibilities The medical products and services outfit is not flashy, but it may benefit from long-term trends. Their stock may be worth monitoring. |
IndustryWeek
June 1, 2007
Traci Purdum |
500 Largest U.S. Manufacturers: Manufacturing Giants This group of manufacturing leaders is demonstrating how to stay competitive in a global economy. |
The Motley Fool
June 2, 2005
Brian Gorman |
Hospira's Little Purchase There may be more to Hospira's recent acquisition than meets the eye. |
Nursing Management
December 2009
Rebecca J. Zapatochny Rufo |
Proven again... innovative integration of the virtual ICU in long-term care The virtual ICU allows a centralized intensivist-led care team to continuously monitor, assess, and intervene in support of on-site caregivers. |
The Motley Fool
October 20, 2005
Stephen D. Simpson |
Baxter Needs Growth Infusion This is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go. Trading at nearly 20 times forward earnings, it seems like expectations of a growth revival are already in the stock. |
IndustryWeek
September 1, 2006
David Blanchard |
Hospira CEO Chris Begley -- Diagnosis: Green and Lean Chris Begely says manufacturers should become more environmentally responsible. What's more, he's doing something about it. |
